Published on
February 25, 2025
- 14:30 GMT
BioAdvance Capital Fuels Life Sciences Innovation with Nine New Investments
Expands Portfolio with Cutting-Edge Innovations in Gene Therapy, AI-Driven Drug Discovery, and Precision Medicine PHILADELPHIA, PA, UNITED STATES, February 25, 2025 /EINPresswire.com/ -- In 2024, BioAdvance Capital continued its mission to foster early- …
Distribution channels:
Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry
...
